Glaukos Corporation

Glaukos Corporationverified

GKOS

Price:

$109.79

Market Cap:

$5.53B

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The ...[Read more]

Industry

Medical - Devices

IPO Date

2015-06-25

Stock Exchange

NYSE

Ticker

GKOS

The PE Ratio as of May 2024 (TTM) for Glaukos Corporation (GKOS) is -38.12

According to Glaukos Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -38.12. This represents a change of 37.44% compared to the average of -27.73 of the last 4 quarters.

Glaukos Corporation (GKOS) Historical PE Ratio (quarterly & annually)

How has GKOS PE Ratio performed in the past?

The mean historical PE Ratio of Glaukos Corporation over the last ten years is -955.03. The current -38.12 PE Ratio has changed 299.15% with respect to the historical average. Over the past ten years (40 quarters), GKOS's PE Ratio was at its highest in in the December 2016 quarter at 2.15K. The PE Ratio was at its lowest in in the March 2019 quarter at -517.85.

Quarterly (TTM)
Annual

Average

-955.03

Median

-28.21

Minimum

-9585.57

Maximum

249.76

Glaukos Corporation (GKOS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Glaukos Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 49.50%

Maximum Annual PE Ratio = 249.76

Minimum Annual Increase = -3937.86%

Minimum Annual PE Ratio = -9585.57

Quarterly (TTM)
Annual
YearPE RatioChange
2023-28.5936.85%
2022-20.89-49.78%
2021-41.6049.50%
2020-27.83-121.09%
2019131.92-186.90%
2018-151.81-98.42%
2017-9585.57-3937.86%
2016249.76-2255.94%
2015-11.58-81.92%
2014-64.074.23%

Glaukos Corporation (GKOS) Average PE Ratio

How has GKOS PE Ratio performed in the past?

The current PE Ratio of Glaukos Corporation (GKOS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-30.36

5-year avg

2.60

10-year avg

-955.03

Glaukos Corporation (GKOS) PE Ratio vs. Peers

How is GKOS’s PE Ratio compared to its peers?

Glaukos Corporation’s PE Ratio is less than OrthoPediatrics Corp. (-33.26), less than CONMED Corporation (27.93), greater than LivaNova PLC (-105.40), less than Paragon 28, Inc. (-11.75), less than Orthofix Medical Inc. (-4.48), less than NuVasive, Inc. (68.48), greater than Heska Corporation (-91.49), less than Bruker Corporation (27.14), less than Nevro Corp. (-5.03), less than Integer Holdings Corporation (41.27), less than IRadimed Corporation (29.69), less than Surmodics, Inc. (36.29), less than Sight Sciences, Inc. (-4.83),

Build a custom stock screener for Glaukos Corporation (GKOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glaukos Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Glaukos Corporation (GKOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Glaukos Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Glaukos Corporation's PE Ratio?

How is the PE Ratio calculated for Glaukos Corporation (GKOS)?

What is the highest PE Ratio for Glaukos Corporation (GKOS)?

What is the 3-year average PE Ratio for Glaukos Corporation (GKOS)?

What is the 5-year average PE Ratio for Glaukos Corporation (GKOS)?

How does the current PE Ratio for Glaukos Corporation (GKOS) compare to its historical average?